1997年

1. Sasayama S, Matsumori A, Weizhong Wang: Amlodipine inhibits nitric oxide production in murine model of heart failure; a potential therapeutic benefit. 5th World Congress of Heart Failure. May 13, Washington DC.
2. Sasayama S: Cytokines in heart failure: immunomodulation in heart failure. Heart Failure '97 2nd International Meeting organized under the auspices of the Working Group on Heart Failure. May 25, Cologne.
3. Sasayama S: State-of-the-Art; Immunological aspects of cardiovascular therapeutics congestive heart failure. 7th International Symposium on Cardiovascular Pharmacotherapy. June 2, Jerusalem.
4. Sasayama S: State-of-the-Art; Newer aspects of cardiovascular therapeutic immunomodulation. 7th International Symposium on Cardiovascular Pharmacotherapy. June 4, Jerusalem.
5. Sasayama S: Cytokines and heart failure. The Maryland Symposium on Humoral Mechanisms of Heart Failure: From Basic to Clinical Research. September 24, Baltimore.
6. Sasayama S: Cytokines and heart failure. University of Cincinnati Cardiovascular Center, Cardiology Seminar. September 25, Cincinnati.
7. Sasayama S, Matsumori A: Effects of the angiotensin II-receptor antagonist candesartan cilexetil on the treatment of heart failure in clinical and experimental settings. International Symposium on Angiotensin II Antagonism: Advances in Pharmacology and Therapeutics with Angiotensin II-Receptor Antagonists. September 29, London.
8. Sasayama S: A potential therapeutic benefit of immunomodulation. 49th Annual Scientific Congress of the Korean Association of Internal Medicine. October 24, Seoul.
9. Sasayama S: Pathophysiology of Heart Failure. Cardiology Seminar, Yonsei University, School of Medicine. October 24, Seoul.
10. Sasayama S: Pathophysiology of Heart Failure. Invited lecture in Samsung Hospital. October 25, Seoul.
11. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S: Detection of hepatitis C virus from the heart of patients with dilated and hypertrophic cardiomyopathies. Heart Failure'97. Second International Meeting organised under the auspices of the Working Group on Heart failure. May 24-27, Cologne.
12. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S: Hepatitis C virus infection in patients with dilated and hypertrophic cardiomyopathies. 7th International Symposium on Cardiovascular Pharmacotherapy. June1-6, Jerusalem.
13. Matsumori A: Cytokine inhibitors: A new therapeutic insight into heart failure. Asian Pacific Cardiovascular Update 1997. June 5-6, Shatin.
14. Igata H, Ono K, Matsumori A, Sasayama S: Effect of TAK-044 on survival and myocardial damage in viral myocarditis. Fifth International Conference on Endothelin. September 12-15, Kyoto.
15. Matsumori A, Ohashi N, Kakio T, Hara T, Nishio R, Ono K, Furukawa Y, Shioi T, Matoba Y, Sasayama S: Detection of hepatitis C virus from the heart of patients with dilated and hypertrophic cardiomyopathies. The Fifth International Symposium on Cardiomyopathy and Myocarditis (ISCM-TOKYO)September 30-October 2, Tokyo.
16. Matsumori A: Molecular and immune mechanism in the pathogenesis of myocarditis and cardiomyopathy. Role of hepatitis C virus, cytokines, and nitric oxide. The Fifth International Symposium on Cardiomyopathy and Myocarditis (ISCM-TOKYO)September 30-October 2, Tokyo.
17. Matsumori A: Virology expert panel of the ISFC/WHO task of the council on cardiomyopathies on the definition and classification of myocarditis. International Society and Federation of Cardiology, Scientific Council on Cardiomyopathies, October 3-5, Marburg.
18. Furukawa Y, Ono K, Shioi T, Matsushima K, Matsumori A: Anti-monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 antibody inhibits neointimal hyperplasia in rats. The 70th Scientific Sessions of the American Heart Association. November 9-12, Orlando.
19. Matsumori A: Symposium. Heart Failure: Pathophysiological roles of cytokines as amolecular component of heart failure. The 70th Scientific Sessions of the American Heart Association. November 9-12, Orlando.
20. Ono K, Shioi T, Furukawa Y, Matsumori A: Recombinant rat hepatocyte growth factor induces capillary endothelial regeneration in a rat model of myocardial ischemia and reperfusion. The 70th Scientific Sessions of the American Heart Association. November 9-12, Orlando.
21. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Kakio T, Ohashi N, Hara M: cardiomyopathy associatedwith hepatitis C virus infection. The 70th Scientific Sessions of the American Heart Association. November 9-12, Orlando.
22. Nawada R, Kouchi I, Haruna T, Tsuchiya K, Akao M, Horie M, Murakami T: Interaction of ATP-sensitive potassium channels and Na+/K+ ATPase in ischemic preconditioning. The70th Scientific Sessions of American Heart Associacion. November 9-12, Orlando.
23. Kouchi I, Murakami T, Akao M: Role of ATP-sensitive potassium channels in calcium preconditioning in rabbit hearts. The70th Scientific Sessions of American Heart Associacion. November 9-12, Orlando.
24. Kouchi I, Kihara Y, Inoko M, Akao M, Tomita T, Murakami T, Sasayama S: β-adrenergic signal transduction during transition from left ventricular hypertrophy to failure in Dahl salt-sensitive rats. Heart Failure '97 2nd International Meeting of the Working Group on Heart Failure. May 24-27, Cologne.
25. Kouchi I, Iwase T, Murakami T, Kashiwagi N, Sasayama S: A novel extracorporeal granulotrap column, G-1 reduces infarct size without a complete depletion of neutrophils in rabbit hearts. International Society for Heart Research The 14th Annual meeting of the Japanese Section. July 18-19, Asahikawa.
26. Muso E, Mune M, Fujii Y, Imai E, and Kinki-FGS LDL-apheresis Treatment (K-FLAT)study group: Significantly rapid induction to remission of steroid-resistant nephrotic syndrome (NS)by LDL-apheresis (LDL-A)Multicenter control study 14th International Society of Nephrology, May 25-29, Sydney.
27. Suyama K, Muso E, Kawamura T, Kamata T, Sasayama S: Specific amelioration if impaired natriuresis by an ace inhibitor with biliary excretion (Temocapril: Tem)in pan-induced 'Malignant' FGS in hypertensive rats (SHR)The 30th Annual Meeting of The American Society of Nephrology. November 2-5, San Antonio.
28. Kawamura T, Muso E, Ono T, Miyawaki S, Yoshida H, Sasayama S: Deposition of fibronectin markedly increase in Th endothelial side of thickened glomerular basement membrane in high serum IgA ddY (HIGA)mice. The 30th Annual Meeting of The American Society of Nephrology. November 2-5, San Antonio.
29. Sakurai M, Muso E, Matsushima H, Kamata T, Suyama K, Ono T, Sasayama S: Low dencity lipoprotein apheresis (LDL-A)specifically recovered suppressed IL-8 secretion from PBMC in response to LPS in steroid resistance nephrotic syndrome due to FGS. The 30th Annual Meeting of The American Society of Nephrology. November 2-5, San Antonio.
30. Nogaki F, Muso E, Kamata T, Suyama K, Oyama A, Miyawaki S, Yoshida H, Sasayama S: Age associating relative shift to Th2 predominance with elevation of IL-4 and TGF-ｧ production of CD4+ spleen cells from hifh IgA strain (HIGA)of ddY mice. The 30th Annual Meeting of The American Society of Nephrology. November 2-5,San Antonio.
31. Nogaki F, Muso E, Yashiro M, Sasayama S: Simvastatin (Sm)suppresses the proliferation of cultured murine mesangial cells through PDGF suppression and matrix protein synthesis independent of TGF- expression. The 30th Annual Meeting of The American Society of Nephrology. November 2-5, San Antonio.
32. Haku E, Muso E, Nogaki F, Kawamura T, Sakurai M, Suyama K, Ono T, Sasayama S, Uno K, Kishida T: Whole blood interferon-producing capacities (IFN-PCs)in clinically stable IgA nephropathy (IgA-N)patients. The 30th Annual Meeting of The American Society of Nephrology. November 2-5, San Antonio.
33. Imasawa T, Nagasawa R, Utsunomiya Y, Kawamura T, Makita N, Yu Z, Muso E, Maruyama N, Hosoya T, Ohno T, Sakai O: Etiopathogenesis of IgA nephropathy may lie in disordered hemopoietic stem cells. The 30th Annual Meeting of The American Society of Nephrology. November 2-5, San Antonio.
34. Tanaka T, Fujita M, Ikemoto M, Otani H, Minowa M, Nohara R, Tamaki S, Yamazato A, Sasayama S: potentiation of human vascular smooth muscle cell growth by pericardial fluids from patients with unstable angina. The 46th Annual Scientific Session of the American College of Cardiology. March 16-19, Anaheim.
35. Inada H, Nohara R, Kawanami M, Hosokawa R, Hirai T, Oka N, Awazu C, Fujita M :Circadian variation of baroreflex sensitivity in diabetic and non-diabetic patients with cardiac disease. The 70th Scientific Meeting of the American Heart Association. November 9-12, Orlando.
36. Pristipino C, Finocchiaro ML, Beltrame JF, Mongiardo R, Sanna T, Cianflone D, Parisi N, Tamaki S, Yoshida A, Hattori R, Fujita M, Maseri A: Differences in coronary vasospastic response after recent myocardial infarction n Japanese and Caucasian patients. The 70th Scientific Meeting of the American Heart Association. November 9-12, Orlando.
37. Hata T, Nohara R, Hosokawa R, Fujita M, Kudo T, Konishi J, Tamaki N: Regional oxidative metaoblism, blood flow and wall thickening in patients with ischemic heart disease with and without old myocardial infarction: Relation to low dose dobutamine-induced changes and improvement of wall motion after coronary revascularization. The 70th Scientific Meeting of the American Heart Association. November 9-12, Orlando.
38. Nohara R, Hosokawa R, Linxue L, Tamaki S, Hashimoto T, Tanaka M, Miki S, Sasayama S: Long-Term cholesterol-lowering treatment and myocardial perfusion. 3rd International Conference of Nuclear Cardiology. April 6-9, Florence, Italy.
39. Nohara R, Hosokawa R, Linxue L, Tamaki S, Hashimoto T, Tanaka M, Miki S, Sasayama S: Recent advance of 123-I BMIPP imaging in coronary artery disease. Basic experiments in animal model. 3rd International Conference of Nuclear Cardiology. April 6-9, Florence, Italy.
40. Hata T, Nohara R, Hosokawa R, Fujita M, Sasayama S: Evaluation of myocardial distribution of iodine-123 metaiodobenzylguanidine (123I-MIBG)in athlete's heart. 3rd International Conference of Nuclear Cardiology. April 6-9, Florence, Italy.
41. Hirai T, Nohara R, Hosokawa R, Fujibayashi Y, Tanaka M, Sasayama S: Evaluation of flow and metabolism in rat heart using "PINHOLE" SPECT system. 3rd International Conference of Nuclear Cardiology. April 6-9, Florence, Italy.
42. Hosokawa R, Nohara R, Fujibayashi Y, Hata T, Fujita M, Sasayama S: Back diffusion of BMIPP plays an important role in perfusion/metabolism mismatch on SPECT images with ischemia. 3rd International Conference of Nuclear Cardiology. April 6-9, Florence, Italy.
43. Hosokawa R, Nohara R, Okuda K, Fujibayashi Y, Ogino M, Hirai T, Fujita M, Magata Y, Konishi J, Sasayama S: The clinical usefulness of I-123 BMIPP SPECT images in detecting the severity of hibernating myocardium. Comparison with myocardial blood flow and F-18 FDG. Scientific Abstracts of the 44th Annual Meeting of the Society of Nuclear Medicine. June 1-5, San Antonio, Texas.
44. Tadamura E, Konishi J, Nishimura K, Matsuda K, Ban T, Nohara R, Sasayama S, Tamaki N: Myocardial perfusion and metabolism reflect myocardial histological change in ischemic myocardium in man. Scientific Abstracts of the 44th Annual Meeting of the Society of Nuclear Medicine. June 1-5, San Antonio, Texas.
45. Inubushi M, Magata Y, Konishi J, Matsumori A, Nohara R, Sasayama S, Yoshibayashi M, Tamaki N: Decreased BMIPP uptake precedes the impairment of oxygen and glucose metabolism in patients with hipertrophic cardiomyopathy. Scientific Abstracts of the 44th Annual Meeting of the Society of Nuclear Medicine. June 1-5, San Antonio, Texas.
46. Hata T, Nohara R, Hosokaw R, Fujita M, Kudoh K, Konishi J, Sasayama S: Effects of amlodipine on silent myocardial ischemia after healing of acute myocardial infarction-evaluation by continuous ventricular function monitoring (VEST)and carbon-11 acetate PET-. 3rd European Meeting on Calcium Antagonists. October 29-31, Amsterdam, Netherlands.
47. Kudoh T, Hattori N, Inubushi M, Tadamura E, Magata Y, Konishi J, Nohara R, Hosokawa R, Hata T: C-11 Acetate PET with low -dose dobutamine infusion can delineate viable myocardium: comparison with FDG-PET. The 70th Scientific Meeting of the American Heart Association. November 9-12, Orlando.
48. Inada H, Nohara R, Kawanami M, Hosokawa R, Hirai T, Oka N, Awadzu C, Fujita M: Circadian variation of baroreflex sensitivity in diabetic and non-diabetic patients with cardiac disease. The 70th Scientific Meeting of the American Heart Association. November 9-12, Orlando.
49. Hata T, Nohara R, Hosokawa R, Fujita M, Kudo T, Konishi J, Tamaki N: Regional oxidative metabolism, blood flow and wall thickening in patients with ischemic heart disease with and without old myocardial infarction: Relation to low dose dobutamine-induced changes and improvement of wall motion after coronary revascularization.The 70th Scientific Meeting of the American Heart Association. November 9-12, Orlando.
50. Hosokawa R, Nohara R, Hata T, Kudoh T, Tamaki N: Metabolical resemblance of left bundle branch block to hibernating myocardium: validation by C-11 acetate PET and echocardiography. The 70th Scientific Meeting of the American Heart Association. November 9-12, Orlando.
51. Horie M, Ishida-Takahashi A, Washizuka T, Otani H, Tsuji K, Takahashi C, Noda M, Sasayama S: Functional correlation between Cystic Fibrosis Transmembrane Conductance Regulator and Kir 6.1, an inwardly-rectifying K channel with two transmembrane segments. International Symposium on ABC superfamily, February 2, Kyoto.
52. Ishida-Takahashi A, Horie M, Washizuka T, Otani H, Sasayama S: Cystic fibrosis transmembrane conductnace regulator confers sensitivity to sulfonylureas on Kir6.1, an inwardly-rectifying K channel, expressed in NIH3T3 cells. The 41st Biophysics Society Meeting. March 2-6, New Orleans.
53. Kojima J, Kihara Y, Ushiyama T, Kida M, Nakajima H, Sasayama S: Noninvasive assessment of the pressure-area relationship in the abdominal aorta disclosed distinct increase in arterial stiffness with ischemic heart disease. The 7th Asian-Pacific Conference on Doppler and Echocardiography, May 14-16, Osaka.
54. Iwanaga Y, Y. Kihara, S. Sasayama: Differential Pathophysiological Roles of Angiotensin II Versus Endothelin-1 in the Ventricular Myocardium During Transition From Pressure-Overload Hypertrophy to Heart Failure in Dahl Hypertensive Rats. 70th AHA Scientific Sessions. November 10-12, Orland.
55. Ono T, Muso E, Sasayama S: The effect of combined therapy on cross linked fibrin(XFb)deposition in crescentic glomerulonephritis with ANCA-related and -unrelated vasculitis. ANCA and vasculitis symposium. May30 -June 1, Melbourne.
56. Ono T, Cunningham M, Hewitson TD, Becker GJ, Holdsworth SR:Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis. The XIV international congress of nephrology. May 25-29, Sydney.
57. Makino T, Ono T, Muso E, Honda G: Perilla extract inhibits cytokine-induced proliferation and stimulates nitric oxide production of murine cultured mesangial cells. International symposium on natural medicines. October 28-30, Kyoto.
58. Ono T, Liu Ning, Kasuno K, Nogaki F, Kamata T, Suyama K, Muso E, Sasayama S: Mesangial expression of factor V in glomerulonephritis and in cultured cells. The 30th Annual Meeting of The American Society of Nephrology. November 2-5, San Antonio.
59. Araki M, Tanaka M, Hasegawa K, Sasayama S: Blockade of nitric oxide improve myocardial metabolism during ischemia independent of preconditioning effect, American College of Cardiology, March 16-19, Anaheim.
60. Hasegawa K, Kitsis RN: Transcriptional Coactivator p300 Activates Muscle-Specific Gene Expression in Cardiac Myocytes, Keystone Symposia, April 1-6, Colorado.
61. Hasegawa K, Kitsis RN: cis-Acting Elements that Mediate Induction of β-Myosin Heavy Chain Gene Expression During Left Ventricular Hypertrophy due to Aortic Constriction, World Congress on Heart Failure, May 11-14, Washington.
62. Kaburagi S, Hasegawa K, Morimoto T, Araki M, Sasayama S: A role of endothelin converting enzyme-1 in the development of hypertrophy in cultured neonatal cardiac myocytes, Fifth International Conference on Endothelin, September 12-15, Kyoto.
63. Kaburagi S, Morimoto T, Araki M, Hasegawa K: Accelerated Conversion of Big Endothelin-1 to Endothelin-1 in α1 -Adrenergic- Stimulated Cardiac Myocytes is Involved in the Development of Hypertrophy and the Activation of β-Myosin Heavy Chain Gene Transcription, American Heart Association, November 9-12, Orlando.
64. Morimoto T, Hasegawa K, Kaburagi S, Sasayama S: A GATA Element is Required for Leukemia Inhibitory Factor-Responsive Transcription of the β-Myosin Heavy Chain Gene During Cardiac Hypertrophy, American Heart Association, November 9-12, Orlando.
65. Hasegawa K, Jee JS, Jobe SM, Markham BE, Kitsis RN: AGATA Element Mediates Aortic Constriction-Responsive Transcription of the β-Myosin Heavy Chain Gene During Cardiac Hypertrophy in Intact Adult Rats, American Heart Association, November 9-12, Orlando.
66. Urayama S, Matsuda T, Sugimoto N, Uyama C：Motion Analysis of Left Ventricular Myocardium Using an MR Tagging Methodwith Narrow Stripes, World Congress on Medical Physics and BiomedicalEngneeringm, Septermber 14-19, Nice.
67. Pristipino C, Finocchiaro ML, Beltrame JF, Mongiardo R, Sanna T, Cianflone D, Parisi N, Tamaki S, Yoshida A, Hattori R, Fujita M, Maseri A: Differences in coronary vasospastic response after recent myocardial infarction in Japanese and Caucasian patients. The 70th Scientific Meeting of the American Heart Association.November 9-12, Orlando.

Copyright(C) by Department of the circulatory organs,
Kyoto University Hospital. All Rights Reserved.